In an early-release Oct. 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, the CDC presents interim guidance to help clinicians assess, evaluate, manage, and follow patients with electronic cigarette, or vaping, product use-associated lung injury.
Using the GRADE system to review new evidence, a panel issued weak recommendations for colorectal cancer screening options based on estimated 15-year individual risk.
A Clinical Update review published in JAMA detailed current research surrounding the efficacy and safety of obesity treatment for adolescents, including behavioral interventions, pharmacotherapy, and bariatric surgery.
The innovative use of fractionation of laser beam technology in dermatology has led to significant improvements in the treatment of burn scars, regardless of how mature.
The benefits of early diagnosis of chronic kidney disease (CKD) are significant, as patients in whom CKD is diagnosed in the early stages have the chance to make lifestyle changes, learn how to manage their disease, and extend their lives while avoiding or postponing the need for dialysis or transplant.
The Tsimane’ Amazonian Panel Study sought to investigate the effect of modernization and market exposure on the health of Bolivia’s Tsimane’ forager-horticulturalists.
Adult exposure to economic hardship (EH) results in worse aging outcomes in midlife, including reduced physical and cognitive capabilities and higher levels of certain inflammatory markers, according to a study published in the European Journal of Ageing. Investigators obtained yearly data on household income from Statistics Denmark from the period of 1987 through 2008. EH…
Because unmarried patients are less likely to choose surgery or radiotherapy treatments over other interventions, researchers often speculate that those patients have less “fighting spirit” or that having a life partner would give them “more to live for.”
The therapeutic potential of cannabinoids to manage several clinical conditions, including pain, inflammation, sleep disorders, and epilepsy, is finding support through a growing body of evidence.
Although an estimated 82 million people worldwide will be affected by dementia by 2030, research demonstrates that cognitive decline often goes unrecognized in primary care settings.
